Advance NanoTek Limited (BBJ) - Total Liabilities

Latest as of June 2024: €3.36 Million EUR ≈ $3.93 Million USD

Based on the latest financial reports, Advance NanoTek Limited (BBJ) has total liabilities worth €3.36 Million EUR (≈ $3.93 Million USD) as of June 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Advance NanoTek Limited - Total Liabilities Trend (2014–2024)

This chart illustrates how Advance NanoTek Limited's total liabilities have evolved over time, based on quarterly financial data. See Advance NanoTek Limited short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Advance NanoTek Limited Competitors by Total Liabilities

The table below lists competitors of Advance NanoTek Limited ranked by their total liabilities.

Company Country Total Liabilities
Pivotree Inc
V:PVT
Canada CA$5.66 Million
Morgan Sindall Group PLC
LSE:MGNS
UK GBX1.57 Billion
Garda Tujuh Buana Tbk
JK:GTBO
Indonesia Rp7.99 Million
Pato Chemical Industry Public Company Limited
BK:PATO
Thailand ฿75.17 Million
Triniti Dinamik PT Tbk
JK:TRUE
Indonesia Rp536.54 Billion
East Asia Holdings Investment Limited
KQ:900110
Korea ₩18.10 Billion
Hulamin
JSE:HLM
South Africa ZAC3.66 Billion
Lyka Labs Limited
NSE:LYKALABS
India Rs664.32 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Advance NanoTek Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BBJ market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 8.30 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.10 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.09 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Advance NanoTek Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Advance NanoTek Limited (2014–2024)

The table below shows the annual total liabilities of Advance NanoTek Limited from 2014 to 2024.

Year Total Liabilities Change
2024-06-30 €3.36 Million
≈ $3.93 Million
-11.06%
2023-06-30 €3.78 Million
≈ $4.42 Million
+15.25%
2022-06-30 €3.28 Million
≈ $3.83 Million
-49.61%
2021-06-30 €6.51 Million
≈ $7.61 Million
+46.26%
2020-06-30 €4.45 Million
≈ $5.20 Million
+199.20%
2019-06-30 €1.49 Million
≈ $1.74 Million
-5.37%
2018-06-30 €1.57 Million
≈ $1.84 Million
-0.05%
2017-06-30 €1.57 Million
≈ $1.84 Million
-10.28%
2016-06-30 €1.75 Million
≈ $2.05 Million
-15.61%
2015-06-30 €2.08 Million
≈ $2.43 Million
+12.55%
2014-06-30 €1.85 Million
≈ $2.16 Million
--

About Advance NanoTek Limited

F:BBJ Germany Chemicals
Market Cap
$30.17 Million
€25.81 Million EUR
Market Cap Rank
#24151 Global
#2101 in Germany
Share Price
€0.41
Change (1 day)
-0.48%
52-Week Range
€0.30 - €0.68
All Time High
€4.42
About

Advance ZincTek Limited, together with its subsidiaries, manufactures aluminum oxide powder, and zinc oxide dispersions and powder for use in the personal care sector in Australia, the United States, Canada, Europe, and internationally. The company produces and distributes dispersion of mineral-only UV filters in cosmetic emollients that are used for sunscreen, skincare, and pharmaceutical formul… Read more